Top Markets
Coin of the day
BIOLASE, Inc. BIOLASE, Inc.

BIOLASE, Inc.

BIOL
株式のランク #42643
BIOLASE, Inc., along with its various divisions, operates as a global... BIOLASE, Inc., along with its various divisions, operates as a global enterprise specializing in the creation, production, distribution, and sale of advanced laser systems. These technologies are specifically designed for dental professionals and their patients across the United States and internationally. The sophisticated laser instruments developed by BIOLASE empower a diverse array of dental specialists—including general dentists, periodontists, endodontists, and oral surgeons—to execute a broad spectrum of minimally invasive procedures. These applications range from cosmetic enhancements and restorative treatments to intricate surgical interventions. Among its core product offerings, the company provides Waterlase all-tissue dental laser systems, which are highly effective for precisely cutting both soft and hard tissues. It also supplies diode soft-tissue laser systems, utilized for procedures involving soft tissue, pain management, teeth whitening, and various other aesthetic treatments. Furthermore, the Epic Hygiene laser assists in addressing non-surgical periodontitis and enhancing overall clinical efficiency. Beyond its primary laser devices, BIOLASE also manufactures and distributes essential consumable items and accessories. This comprehensive range includes flexible fibers, specialized hand pieces, and professional teeth whitening gel kits. The company markets its products through a dedicated in-house sales team and an extensive network of distributors. Established in 1984, the organization was initially known as BIOLASE Technology, Inc., before officially changing its name to BIOLASE, Inc. in 2012. Its corporate headquarters are situated in Foothill Ranch, California.
株価
$0.00695
最終同期: 2024-10-29
時価総額
$536.40
変化(1日)
-0.71%
変化(1年)
0.00%
US
取引 BIOLASE, Inc. (BIOL)

カテゴリー

BIOLASE, Inc.(BIOL)の営業利益率
August 2026 時点の営業利益率 TTM: -36.48%
BIOLASE, Inc. の最新の財務報告と株価によると、現在の営業利益率(TTM)は -36.48% です。2022 年末時点では -52.28% でした。
BIOLASE, Inc. の営業利益率の履歴(2000 から 2026)
各年末の営業利益率
営業利益率 変化
2026 (TTM) -36.48% 0.00%
2023 -36.48% -30.22%
2022 -52.28% 27.14%
2021 -41.12% -49.47%
2020 -81.37% 96.88%
2019 -41.33% -8.66%
2018 -45.25% 17.72%
2017 -38.44% 33.10%
2016 -28.88% -29.70%
2015 -41.08% 9.11%
2014 -37.65% 93.18%
2013 -19.49% 341.95%
2012 -4.41% -46.22%
2011 -8.20% -81.29%
2010 -43.83% 541.73%
2009 -6.83% -49.74%
2008 -13.59% 1.34%
2007 -13.41% 93.23%
2006 -6.94% -74.67%
2005 -27.40% 77.58%
2004 -15.43% -201.78%
2003 15.16% 78.35%
2002 8.50% -518.72%
2001 -2.03% -94.60%
2000 -37.62% 0.00%
同業他社の営業利益率
企業 営業利益率 営業利益率の差
17.03% -100.47%
US
22.03% -100.60%
US
17.86% -100.49%
IE
21.46% -100.59%
US
28.09% -100.77%
US
企業の営業利益率とは?
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。